Stratification of patients according to presence of gastrointestinal bleeding, ascites or hepatorenal syndrome did not show significant differences in portal or hepatic vein levels of MCP-1 (SI-Table 5). This evidence concerns the gene CCL2 and hepatorenal syndrome.